|
To learn more about Jazz Pharmaceutical’s ZIIHERA, click here.
Register by May 26 for Complimentary Member Pricing!Details >
• AVYXASSIST™
• IncyteCARES
• ServierONE Details >
• CMS CLIA Communications Update
• We Want Your Comments: SRT for the Treatment of NMSC
• Upcoming Events
• Upcoming Closure
• Medicare Hot Links Details >New training opportunities availableDetails >
Recent Oncology Related Articles• 2025 CAHPS for MIPS Survey
• 2025 QPP Exception Applications Now Available
• Suspension of 8 Improvement Activities for MIPS
• MLN Matters Details >This edition includes articles on• 340B Savings Must Continue to Drive Local Investment in Healthcare
• Verifying the Authenticity of Federal Contacts
• Why Price Transparency is a Rare Unifying Issue
• Weaponing the OIG
• The Undoing of SDoH Reporting Details >
Recent Oncology Related News• Management of Oncology Medical Benefit Drugs Changes - June 1
• Trazimera Preferred Trastuzumab Product - May 12
• Step Therapy Required for Keytruda & Opdivo for NPC- June 18
• Piasky & Tremfya Have Site-of-Care Requirement - June 1
• Alyglo, Amtagvi, & Loqtorzi Have Requirements - Starting June 1 Details >Publications• The Record
• BCN Provider News Details >
• Update! Procrit or Epoetin Class Drugs Maintenance
• BCBSM Below Cost Reimbursement Details >• 0885 Claims Denied With Reason Code 693
• Procrit or Epoetin Class Drugs Maintenance
• Procrit Denials (693)
• 505(b)(2) Oncology Products Being Impacted by Prior Auth Details >• May 2025 OfficeLink Update
• Drugs Not Covered - And Their Covered Alternatives Details >• Claim Pattern Review Program for Professional Claims
• Plans Offered Through HAP CareSource
• Pharmacy Information
• Preferred Lab Partner
• And More Details >Recent Oncology Related News• Preferred Drug List Details >• Update to Supervising Claim Voids
• Record Keeping Reminder
• MMP Bulletin Details >• Digestive Health Support Platform Available June 1
• Food Delivery Services Covered for Some Members Starting June 1
• Commercial & Medicaid Formulary Changes Taking Effect
• May 2025 Billing Policy Updates
• And More Details >• Medical Policy Updates
• Reimbursement Policy Updates
• Pharmacy and Clinical Updates
• Advance Notification and Prior Authorization Requirements
• And More Details >
• Incyte Zynyz® (retifanlimab-dlwr)
• Abbvie Emrelis™ (telisotuzumab vedotin-tllv)
• Merck Welireg® (belzutifan) Details > 
Encourage Your Patients to Participate!Details >
May 2025 Frequently Asked Questions• 96376 Reported in Conjunction With 96374 or 96375
• Oral Hydration VS Intravenous Hydration Therapy Details > |
